RSS   Newsletter   Contact   Advertise with us
Post Online Media

Biogen names EVP, pharmaceutical operations & technology

BiogenBiogen, a biotechnology company, appoints Paul McKenzie as EVP, pharmaceutical operations & technology, effective July 1, 2016.
Dr. McKenzie was promoted from his previous position as senior vice president of Global Biologics Manufacturing and Technical Operations.

Dr. McKenzie joined Biogen in February from Johnson & Johnson, where he held a variety of leadership roles, most recently as vice president of R&D for J&J’s Ethicon business.

Prior to that role, Dr. McKenzie led the manufacturing and technical operations team responsible for internal and external manufacturing of Janssen’s pharmaceutical portfolio.

He also ran Global Development for Janssen R&D, helping to manage pipeline activities from discovery through clinical development and commercialization.

Dr. McKenzie also held various R&D and manufacturing positions at Bristol-Myers Squibb and Merck.

Dr. McKenzie graduated from the University of Pennsylvania and received his doctorate in chemical engineering from Carnegie Mellon University.

He replaces John Cox, who last month was named chief executive officer of a new Biogen spin-off company dedicated to advancing treatments for hemophilia.


 LATEST MOVES FROM Massachusetts 


We use cookies to ensure that we give you the best experience on our website. Please allow cookies for fully-functioning website.

Allow Cookies Privacy Policy